TUSC2 and neoplasm: TUSC2 selectively augments natural killer (NK) cells and cytotoxic T lymphocyte (CTL) activity in peripheral blood and in the tumor microenvironment and induces a Th1-mediated immune response, as well as downregulates myeloid-derived suppressor cells (MDSC) and regulatory T cells (Treg)8.